Supreme Court denies W.L. Gore in stent graft patent spat with C.R. Bard
The U.S. Supreme Court refuses to hear an appeal from W.L. Gore & Assoc. in a patent war with C.R. Bard over stent graft technology.
Last October Gore asked the Supremes to consider its appeal of a $186 million patent loss to Bard.
Today the high court denied that bid, whereupon Bard promptly filed a motion to compel payment in the U.S. District Court for Arizona, according to a regulatory filing.